TechConnect Innovation Program

Synthesizing Pharmaceuticals Using Containerless Processing (IN-10-011)

Argonne National Laboratory, Illinois, United States

TECHNOLOGY SUMMARY

A process by which amorphous and nanophase pharmaceutical compounds can be synthesized without the use of a container, thus avoiding potential contamination.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Prototype

Technology Readiness Level: TRL 5

FIGURES OF MERIT

Value Proposition: Competing processes suppress nucleation of crystals by modifying the drug formulation, adding glassy polymer binders that disperse and trap molecules in a disorder form. Our method directly avoids nucleation, without binders, a drug can be formulated in higher purity doses creating drug tablets that provide maximum benefit to the patient.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 707

Website: www.anl.gov

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: Federal Grant

Looking for: Both Funding and Development Partners